Prevalence of nontyphoidal Salmonella serogroups and their antimicrobial resistance patterns in a university teaching hospital in Eastern Province of Saudi Arabia

Infection and Drug Resistance

Volumn 6, Issue , 2013, Pages 199-205

  Elhadi, Nasreldin ^a   Aljindan, Reem ^a   Aljeldah, Mohammed ^a  

^a IMAM ABDULRAHMAN BIN FAISAL UNIVERSITY   (Saudi Arabia)

Author keywords

Antimicrobial resistance; Nontyphoidal Salmonella; Prevalence; Saudi Arabia; Serogroups

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZTREONAM; CEFALOTIN; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; PIPERACILLIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD GROUP TYPING; FECES ANALYSIS; NONTYPHOIDAL SALMONELLA; PREVALENCE; RETROSPECTIVE STUDY; SALMONELLA; SAUDI ARABIA; TEACHING HOSPITAL;

EID: 84888191604     PISSN: 11786973     EISSN: None     Source Type: Journal    
DOI: 10.2147/IDR.S51184     Document Type: Article

References (44)

1. Grimont PAD, Weill F-X. Antigenic formulae of the Salmonellae serovars. 9th ed. Geneva, Switzerland: World Health Organization;2007. Available from: http://www.pasteur.fr/ip/portal/action/WebdriveActionEvent/oid/01s-000036-089. Accessed September 1, 2013.
2. Crum-Cianflone NF. Salmonellosis and the gastrointestinal tract: more than just peanut butter. Curr Gastroenterol Rep. 2008;10:424-431.
3. Scallan E, Hoekstra RM, Angulo FJ, et al. Foodborne illness acquired in the United States-major pathogens. Emerg Infect Dis. 2011;17: 7-15.
4. Centers for Disease Control and Prevention. CDC Estimates of foodborne illness in the United States, 2011. Available from: http://www.cdc.gov/features/dsfoodborneestimates/. Accessed September 1, 2013.
5. Chiu CH, Su LH, Hung CC, Chen KL, Chu C. Prevalence and antimicrobial susceptibility of serogroup D nontyphoidal Salmonella in a university hospital in Taiwan. J Clin Microbiol. 2004;42:415-441.
6. Panhotra BR, Saxena AK, Al-Ghamdi AM. Emerging nalidixic acid and ciprofloxacin resistance in non-typhoidal Salmonella isolated from patients having acute diarrheal disease. Ann Saudi Med. 2004;24: 332-336.
7. Ling JM, Koo IC, Kam KM, et al. Antimicrobial susceptibility and molecular epidemiology of Salmonella enterica serotype Enteritidis strains isolated in Hong Kong from 1986 to 1996. J Clin Microbiol. 1998;36:1693-1699.
8. Rodrigue DC, Tauxe RV, Rowe B. et al. International increase in Salmonella Enteritidis: a new pandemic? Epidemiol Infect. 1990;105: 21-27.
9. Crump JA, Medalla FM, Joyce KW, et al;Emerging Infections Program NARMS Working Group. Antimicrobial resistance among invasive nontyphoidal Salmonella enterica isolates in the United States: National Antimicrobial Resistance Monitoring System, 1996 to 2007. Antimicrob Agents Chemother. 2011;55:1148-1154.
10. Voetsch AC, Van Gilder TJ, Angulo FJ, et al;Emerging Infections Program FoodNet Working Group. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004;38:S127-S134.
11. Majowicz SE, Musto J, Scallan E, et al;International Collaboration on Enteric Disease 'Burden of Illness' Studies. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010;50: 882-889.
12. Hohmann EL. Nontyphoidal salmonellosis. Clin Infect Dis. 2001;32: 263-269.
13. Farmer JJ III. Enterobacteriaceae: introduction and identification. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of Clinical Microbiology. Washington, DC: American Society for Microbiology Press;1995.
14. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI document 2010;M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute;2010. Available from: http://www.techstreet.com/products/1662846. Accessed September 1, 2013.
15. Hammer O, Harper D, Ryan P. Past: Paleontological Statistics Software Package for Education and Data Analysis. Palaeontologia Electronica 2001,4(1):9.
16. Sun S, Negrea A, Rhen M, Andersson DI. Genetic analysis of colistin resistance in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother. 2009;53:2298-2305.
17. Majowicz SE. The global burden of nontyphoidal Salmonella gasteroenteritis. Clin Infect Dis. 2010;50:882-889.
18. Rocourt J, Moy G, Vierk K, et al. The present state of foodborne disease in OECD countries. Geneva, Switzerland: World Health Organization;2003. Available from: http://www.who.int/foodsafety/publications/foodborne_disease/oecd_fbd.pdf. Accessed September 1, 2013.
19. Goldberg MB, Rubin RH. The spectrum of Salmonella infection. Infect Dis Clin North Am. 1988;2:571-598.
20. World Health Organization. The medical impact of the use of antimicrobials in food animals: report and proceedings of a WHO meeting, Berlin, Germany, October 13-17, 1997. Geneva, Switzerland: World Health Organization;1997. Available from: http://whqlibdoc.who.int/hq/1997/WHO_EMC_ZOO_97.4.pdf. Accessed September 1, 2013.
21. Su LH, Chiu CH, Chu C, Ou JT. Antimicrobial resistance in nontyphoid Salmonella serotypes: a global challenge. Clin Infect Dis. 2004;39: 546-551.
22. Tsai MH, Wu SR, Lee HY, et al. Recognition of mechanisms involved in bile resistance important to halting antimicrobial resistance in nontyphoidal Salmonella. Int J Antimicrob Agents. 2012;40:151-157.
23. Swartz MN. Human diseases caused by foodborne pathogens of animal origin. Clin Infect Dis. 2002;34:111-122.
24. McDonald LC, Chen MT, Lauderdale TL, Ho M. The use of antibiotics critical to human medicine in food-producing animals in Taiwan. J Microbiol Immunol Infect. 2001;34:97-102.
25. Helms M, Vastrup P, Gerner-Smidt P, Mølbak K. Excess mortality associated with antimicrobial drug-resistant Salmonella Typhimurium. Emerg Infect Dis. 2002;8:490-495.
26. Varma JK, Molbak K, Barrett TJ, et al. Antimicrobial-resistant nontyphoidal Salmonella is associated with excess bloodstream infections and hospitalizations. J Infect Dis. 2005;191:554-561.
27. Gordon MA, Graham SM, Walsh AL, et al. Epidemics of invasive Salmonella enterica serovar Enteritidis and S. enterica serovar Typhimurium infection associated with multidrug resistance among adults and children in Malawi. Clin Infect Dis. 2008;46:963-969.
28. Kiratisin P. Bacteraemia due to non-typhoidal Salmonella in Thailand: clinical and microbiological analysis. Trans R Soc Trop Med Hyg. 2008;102:384-388.
29. Dhanoa A, Fatt QK. Non-typhoidal Salmonella bacteraemia: epidemiology, clinical characteristics and its association with severe immunosuppression. Ann Clin Microbiol Antimicrob. 2009;8:15.
30. Olsen SJ, Bishop R, Brenner FW, et al. The changing epidemiology of Salmonella: trends in serotypes isolated from humans in the United States, 1987-1997. J Infect Dis. 2001;183:753-761.
31. Lee LA, Puhr ND, Maloney EK, Bean NH, Tauxe RV. Increase in antimicrobial-resistant Salmonella infections in the United States, 1989-1990. J Infect Dis. 1994;170:128-134.
32. Threlfall EJ, Ward LR, Skinner JA, Rowe B. Increase in multiple antibiotic resistance in nontyphoidal salmonellas from humans in England and Wales: a comparison of data for 1994 and 1996. Microb Drug Resist. 1997;3:263-266.
33. Batchelor M, Threlfall EJ, Liebana E. Cephalosporin resistance among animal-associated Enterobacteria: a current perspective. Expert Rev Anti Infect Ther. 2005;3:403-417.
34. Meakins S, Fisher IS, Berghold C, et al;Enter-net Participants. Antimicrobial drug resistance in human nontyphoidal Salmonella isolates in Europe 2000-2004: a report from the Enter-net International Surveillance Network. Microb Drug Resist. 2008;14:31-35.
35. Threlfall EJ. Antimicrobial drug resistance in Salmonella: problems and perspectives in food-and water-borne infection. FEMS Microbiol Rev. 2002;26:141-148.
36. Angulo FJ, Johnson KR, Tauxe TW, et al. Origins and consequences of antimicrobial-resistent nontyphoidal Salmonella: implications for the use of fluoroquinolones in food animals. Microb Drug Resist. 2000;6: 77-83.
37. Voetsch AC, Van Gilder TJ, Angulo FJ, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004;38:S127-S134.
38. Adak GK, Long SM, O'Brien SJ, et al. Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut. 2002;51: 832-841.
39. Kennedy M, Villar R, Vugia DJ, et al;Emerging Infections Program FoodNetWorking Group. Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999. Clin Infect Dis. 2004;38:S142-S148.
40. Vugia DJ, Samuel M, Farley MM, et al;Emerging Infections Program FoodNetWorking Group. Invasive Salmonella infections in the United States, FoodNet, 1996-1999: incidence, serotype distribution, and outcome. Clin Infect Dis. 2004;38:149-156.
41. Berkley JA, Lowe BS, Mwangi I, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med. 2005;352:39-47.
42. Ikumapayi UN, Antonio M, Sonne-Hansen J, et al. Molecular epidemiology of community-acquired invasive non-typhoidal Salmonella among children aged 2-29 months in rural Gambia and discovery of a new serovar, Salmonella enterica Dingiri. J Med Microbiol. 2007;56:1479-1484.
43. Sigaúque B, Roca A, Mandomando I, et al. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J. 2009;28:108-113.
44. Mandomando I, Macete E, Sigaúque B, et al. Invasive non-typhoidal Salmonella in Mozambican children. Trop Med Int Health. 2009;14: 1467-1474.